These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression. Ghaemi SN Bipolar Disord; 2008 Dec; 10(8):957-68. PubMed ID: 19594510 [TBL] [Abstract][Full Text] [Related]
9. Treatment of depression--newer pharmacotherapies. Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454 [TBL] [Abstract][Full Text] [Related]
10. Rationale for, barriers to, and appropriate medication for the long-term treatment of depression. Nutt DJ J Clin Psychiatry; 2010; 71 Suppl E1():e02. PubMed ID: 20371029 [TBL] [Abstract][Full Text] [Related]
11. Relapse rates with long-term antidepressant drug therapy: a meta-analysis. Williams N; Simpson AN; Simpson K; Nahas Z Hum Psychopharmacol; 2009 Jul; 24(5):401-8. PubMed ID: 19526453 [TBL] [Abstract][Full Text] [Related]
12. Antidepressant dose reduction and the risk of relapse in major depressive disorder. Papakostas GI; Perlis RH; Seifert C; Fava M Psychother Psychosom; 2007; 76(5):266-70. PubMed ID: 17700046 [TBL] [Abstract][Full Text] [Related]
13. Treatment of recurrent depression. Fava GA; Park SK; Sonino N Expert Rev Neurother; 2006 Nov; 6(11):1735-40. PubMed ID: 17144786 [TBL] [Abstract][Full Text] [Related]
14. [Long-term treatment with antidepressive drugs]. Lôo H; Brochier T Ann Med Psychol (Paris); 1995 May; 153(3):190-6; discussion 196-7. PubMed ID: 7598353 [TBL] [Abstract][Full Text] [Related]
15. Achieving remission and managing relapse in depression. Thase ME J Clin Psychiatry; 2003; 64 Suppl 18():3-7. PubMed ID: 14700448 [TBL] [Abstract][Full Text] [Related]
16. Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials. McIntyre RS; Muzina DJ; Adams A; Lourenco MT; Law CW; Soczynska JK; Woldeyohannes HO; Nathanson J; Kennedy SH Expert Opin Pharmacother; 2009 Dec; 10(18):3061-75. PubMed ID: 19954275 [TBL] [Abstract][Full Text] [Related]
17. Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder. Perahia DG; Kajdasz DK; Desaiah D; Haddad PM J Affect Disord; 2005 Dec; 89(1-3):207-12. PubMed ID: 16266753 [TBL] [Abstract][Full Text] [Related]
18. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city]. Mouchabac S; Ferreri M; Cabanac F; Bitton M Encephale; 2003; 29(5):438-44. PubMed ID: 14615693 [TBL] [Abstract][Full Text] [Related]
19. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials. Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001 [TBL] [Abstract][Full Text] [Related]
20. Long-term effectiveness of cognitive therapy in major depressive disorder. Hensley PL; Nadiga D; Uhlenhuth EH Depress Anxiety; 2004; 20(1):1-7. PubMed ID: 15368590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]